US Bancorp’s Sonoma Pharmaceuticals SNOA Stock Holding History

US Bancorp’s Portfolio SNOA Stock Details SNOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$53	Hold	25	–	–	﹤0.01%	4137
2025 Q4	$91	Hold	25	–	–	﹤0.01%	4001
2025 Q3	$97	Hold	25	–	–	﹤0.01%	3966
2025 Q2	$71	Hold	25	–	–	﹤0.01%	4120
2025 Q1	$55	Hold	25	–	–	﹤0.01%	4151
2024 Q4	$67	Hold	25	–	–	﹤0.01%	4117
2024 Q3	$77	Hold	25	–	–	﹤0.01%	4039
2024 Q2	$106	Hold	25	–	–	﹤0.01%	3929
2024 Q1	$83	Hold	25	–	–	﹤0.01%	3929
2023 Q4	$90	Hold	25	–	–	﹤0.01%	3921
2023 Q3	$386	Hold	25	–	–	﹤0.01%	3878
2023 Q2	$535	Hold	25	–	–	﹤0.01%	3871
2023 Q1	$488	Hold	25	–	–	﹤0.01%	3949
2022 Q4	$560	Hold	25	–	–	﹤0.01%	3990
2022 Q3	$1K	Hold	25	–	–	﹤0.01%	4003
2022 Q2	$1K	Hold	25	–	–	﹤0.01%	4002
2022 Q1	$2K	Hold	25	–	–	﹤0.01%	3866
2021 Q4	$2K	Hold	25	–	–	﹤0.01%	3923
2021 Q3	$3K	Hold	25	–	–	﹤0.01%	3819
2021 Q2	$4K	Hold	25	–	–	﹤0.01%	3678
2021 Q1	$4K	Hold	25	–	–	﹤0.01%	3562
2020 Q4	$4K	Hold	25	–	–	﹤0.01%	3460
2020 Q3	$4K	Buy	+25	New	+$3.85K	﹤0.01%	3367
2019 Q1	–	Sell	-3	Closed	–	–	3636
2018 Q4	$0	Sell	3 -3	-50%	-$598	﹤0.01%	3681
2018 Q3	$1K	Buy	+6	New	+$2.18K	﹤0.01%	3581

Other funds holding SNOA

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

MCWS

McKinley Carter Wealth Services Wheeling, West Virginia $1.73B AUM 17.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

US Bancorp's SNOA Position: Q1 2026 in Review

US Bancorp held its Sonoma Pharmaceuticals (SNOA) position steady in Q1 2026 at 25 shares worth $53. The position accounts for ﹤0.01% of the portfolio, ranked #4137.

US Bancorp first reported a position in SNOA in Q3 2018 and has held it in 25 quarters since. The position peaked at $4K in Q2 2021. 17 funds tracked by Wall St. Rank hold SNOA as of Q1 2026.

US Bancorp held 25 shares of Sonoma Pharmaceuticals worth $53 as of Q1 2026.
US Bancorp left its Sonoma Pharmaceuticals share count unchanged in Q1 2026.
Sonoma Pharmaceuticals made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #4137 holding.
US Bancorp first reported a position in Sonoma Pharmaceuticals in Q3 2018 and has held it in 25 quarters since.
US Bancorp's Sonoma Pharmaceuticals position peaked at $4K in Q2 2021.
17 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.